146 related articles for article (PubMed ID: 8258331)
1. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents.
Humbert M; Bertolino P; Forquet F; Rabourdin-Combe C; Gerlier D; Davoust J; Salamero J
Eur J Immunol; 1993 Dec; 23(12):3167-72. PubMed ID: 8258331
[TBL] [Abstract][Full Text] [Related]
2. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
[TBL] [Abstract][Full Text] [Related]
3. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
Brooks AG; McCluskey J
J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.
Nadimi F; Moreno J; Momburg F; Heuser A; Fuchs S; Adorini L; Hämmerling GJ
Eur J Immunol; 1991 May; 21(5):1255-63. PubMed ID: 2037011
[TBL] [Abstract][Full Text] [Related]
7. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
Forquet F; Calin V; Trescol-Biemont MC; Kanellopoulos J; Mottez E; Kourilsky P; Rabourdin-Combe C; Gerlier D
Eur J Immunol; 1990 Oct; 20(10):2325-32. PubMed ID: 2242761
[TBL] [Abstract][Full Text] [Related]
8. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
[TBL] [Abstract][Full Text] [Related]
9. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules.
Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C
Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491
[TBL] [Abstract][Full Text] [Related]
10. The invariant chain induces compact forms of class II molecules localized in late endosomal compartments.
Humbert M; Raposo G; Cosson P; Reggio H; Davoust J; Salamero J
Eur J Immunol; 1993 Dec; 23(12):3158-66. PubMed ID: 8258330
[TBL] [Abstract][Full Text] [Related]
11. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
Forquet F; Barois N; Machy P; Trucy J; Zimmermann VS; Leserman L; Davoust J
J Immunol; 1999 Mar; 162(6):3408-16. PubMed ID: 10092796
[TBL] [Abstract][Full Text] [Related]
12. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41.
Peterson M; Miller J
Nature; 1992 Jun; 357(6379):596-8. PubMed ID: 1608470
[TBL] [Abstract][Full Text] [Related]
15. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
Brazil MI; Weiss S; Stockinger B
Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
[TBL] [Abstract][Full Text] [Related]
16. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
17. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells.
Bertolino P; Rabourdin-Combe C
Crit Rev Immunol; 1996; 16(4):359-79. PubMed ID: 8954255
[TBL] [Abstract][Full Text] [Related]
18. C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells.
Sponaas A; Carstens C; Koch N
Gene Ther; 1999 Nov; 6(11):1826-34. PubMed ID: 10602378
[TBL] [Abstract][Full Text] [Related]
19. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
Hitzel C; van Endert P; Koch N
J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
